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Extra Pulmonary Tuberculosis: An 
Overview
Onix J. Cantres-Fonseca, William Rodriguez-Cintrón, 
Francisco Del Olmo-Arroyo and Stella Baez-Corujo
Abstract
Mycobacterium tuberculosis is the bacterium that as a single agent is known 
to cause the infection with the most morbidity and mortality around the world. 
It is known to cause pulmonary infection in immunocompetent patient, but 
its dissemination outside the lungs has been linked to a high degree of cellular 
immunosuppression as seen in the advance stages of human immunodeficiency 
virus infection, and after chemotherapy. Despite extensive research, screening, 
education, and continuous efforts to try to eradicate and control the infection, 
tuberculosis is still one of the most prevalent infections throughout the world. 
Even the cases of extra pulmonary dissemination are seen to have increased. 
Extra pulmonary tuberculous dissemination has a very variable presentation 
that depends on the organ involved. The diagnosis is difficult and many times 
a long time passes between diagnosis and initial presentation. In this chapter, 
we will review how tuberculosis infection presents when the bacilli invades any 
tissue outside the pulmonary parenchyma, what the literature recommends for 
the proper work up and diagnosis, and general treatment for major organ system 
infection.
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1. Introduction
Although it is well known that Mycobacterium tuberculosis can be pathologic to 
any organ system, its manifestations can be so variable that sometimes it becomes a 
challenge for the clinician to identify or even consider it as the cause of the patient’s 
symptomatology. Most of the times, an extensive work up with invasive interven-
tions is required for proper diagnosis.
Extra pulmonary tuberculosis (EPTB), described this way when the tuberculous 
mycobacterium invades areas outside the pulmonary parenchyma, has nonspecific 
clinical findings developing insidiously [1] mimicking other noninfectious condi-
tions [2]. It requires a high clinical suspicion and carries a lengthy period from the 
initial symptoms to the final diagnosis.
Nevertheless, its presentation can be extremely acute causing a life threatening 
condition [1]. Clinical presentation will vary according to the organ system involved 
and more than one organ could be involved at the same time. The initial step in 
early identification is having knowledge of its findings in the proper clinical setting 
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and including them within the differential diagnosis. Even though some patients do 
not have the expected risk factors, tuberculosis is identified as the culprit of symp-
toms associated with other conditions.
This illustrates the ample spectrum of extra-pulmonary tuberculosis manifesta-
tions. Vast medical knowledge helps the clinician to identify this condition in the 
adequate clinical scenario to pursue its diagnosis.
In this chapter, a review of the most important clinical manifestations of extra-
pulmonary tuberculosis will be discussed. It will also review the required work up 
and specific treatment for other organs involved.
2. Epidemiology
Mycobacterium tuberculosis, as a single infectious agent, causes more deaths than 
any other infection [3]. Outside infectious diseases, it is the ninth leading cause 
of death worldwide [3]. According to the World Health Organization (WHO) 
and the Global Tuberculosis report, in 2016, the largest incidence of tuberculosis 
occurred in areas of Korea and Africa [3]. In 2016, more than 10 millions of people 
were infected with tuberculosis around the world [3]. Active tuberculosis occurs 
in approximately 10% of the infected patients, involving lung parenchyma only in 
approximately 85% of subjects [7], but the incidence of other organ involvement 
varies widely in endemic and nonendemic areas.
Worldwide, the incidence of extra-pulmonary involvement of tuberculosis 
occurs in approximately 17–52% of all cases reported [4]. In other publications, 
the incidence from reported cases varies from 15 to 40%, with approximately 3–3.5 
cases per 100,000 of the population from 2002 to 2011 [5]. Although, the incidence 
has been stable or decreased in some areas, a report from 2003 to 2008 showed an 
increased worldwide incidence from 30.6 to 37.6% secondary to longer life expec-
tancy of immunosuppressed patients due to better medical care [6]. In the United 
States, the incidence of EPTB increased from 15.7% of the cases in 1993 to 21.0% 
in 2006 [8]. Therefore, EPTB continues to be an important presentation within 
tuberculosis infectious spectrum.
The demography of EPTB cases varies widely among documented case series. 
A review published in Clinical Infectious Diseases in 2009 [6] revealed that from 
253,299 of tuberculosis cases reported in the USA from 1999 to 2006, 19% were 
extra pulmonary, while 8% were disseminated or concurrently pulmonary and 
EPTB. The mean age of this group was 44 years old, with a proportion of male 
to female almost one to one. Children (described in this population as less than 
15 years old) with reported EPTB were approximately 6% of the cases. This same 
publication revealed predominance of genitourinary and bone and joint involve-
ment in older patients (more than 60-year old), while children accounted for most 
of the cases of meningeal and lymphatic involvement.
3. Organ involvement
Tuberculosis can invade practically any organ. The proportions of organ 
involved in multiple publications suggest that most extra pulmonary tuberculous 
cases are seen with pleural, bone, and lymphatic involvement [6, 9]. In rare cases, 
the involvement can be localized to a specific organ [2], while 2–10% of the cases 
are reported to be disseminated within more than two organ systems [6, 9]. Most 
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4. Risk factors
Multiple populations with tuberculosis have been studied. In a case series 
described by García-Rodríguez et al., the mean age of patients with EPTB was 
higher than patients with pulmonary disease [6]. EPTB cases increased with the 
age, but the anatomical sites varied according to the age [6]. More cases of lym-
phatic, joint, and bone involvement were seen as patients become older. The female 
to male ratio varied according to the organ involvement, but in general, the male to 
female ratio was similar to other publications, which was one to one.
Although immunosuppression seen to be a risk factor for EPTB, a study pub-
lished in International Journal Tuberculosis Lung Disease in 2009 suggested that 
diabetes mellitus was a risk factor for pulmonary tuberculosis, but not for EXPTB 
[10]. The protective mechanism for extra pulmonary dissemination of tuberculosis 
is known. The same study concluded that patients with end stage renal disease had a 
predisposition for EPTB. A possible mechanism that increases the risk for dissemi-
nation is a decrease cell-mediated immune response.
Other risk factors identified for extra-pulmonary dissemination include cirrho-
sis, malignancy, immunosuppressive drug use, alcoholism, HIV infection, chronic 
obstructive pulmonary disease (COPD), congestive heart failure, intravenous drug 
use, previous history of pulmonary tuberculosis, and history of cerebrovascular 
accident. There is not statistical analysis that linked all those causes as a direct risk 
factor for disseminated infection [10].
Cell-mediated immunosuppression has been linked to the development of tuber-
culosis and an increased risk of dissemination. Multiple reports and publications 
have linked HIV infection to the risk of developing EPTB. Among HIV patients 
admitted due to tuberculosis, almost 50% have extra pulmonary involvement [11]. 
Concomitant pulmonary and multi-organ involvement is common. Low counts 
of CD4 lymphocytic cells, which are in charge of cellular immune response, have 
been reported to be directly proportional to systemic dissemination, increasing 
the incidence of central nervous system (CNS) infection. Those patients with CNS 
involvement have higher mortality. Therefore, HIV infection predispose patients to 
EPT and its severity increase when CD4 levels decline to 200 cell/mm3.
5. Pathophysiology
Tuberculosis infection is caused by aerobic bacteria, Mycobacterium tuberculosis. 
Mycobacteria have a cell wall with considerable amount of a fatty acid, mycolic 
acid, attached to a peptidoglycan-bound polysaccharide arabinogalactan, which 
provide a strong barrier resistant to antibiotics and (natural) defense mechanisms 
[12]. Pulmonary tuberculosis is acquired throughout airborne droplets that get into 
lungs and lead to pulmonary infection. Most of the bacteria are trapped in alveolar 
macrophages and destroyed. The mechanism of macrophages engulfment includes 
complement cascade activation when protein C3 binds to the cell wall and enhances 
recognition of the mycobacteria by macrophages. Mycobacterium phagocytosis 
initiates a cascade of events that results in either successful control of the infection, 
followed by latent tuberculosis, or progression to active disease.
After macrophage engulfment, they present the mycobacteria to T cell lym-
phocytes, which generate the formation of granulomas around the organisms. 
Granulomas have low levels of nutrients that restrict mycobacteria growth and 
therefore control the infection. Those patients with decreased immune response 
fail to control the infection and develop primary pulmonary infection. In patients 
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infected, droplets produced during coughing can further spread the infection to 
other patients. Dissemination of the mycobacteria to other organ systems can occur 
when the bacilli get into a blood vessel or throughout the lymphatic system.
Reports suggest that most tuberculous empyemas and patients with vertebral 
bone involvement (Pott’s disease) develop after the transport of tubercle bacilli 
from the pleural spaces to the parasternal and the para-aortic lymph nodes and the 
breakdown of caseous foci in these nodes [13]. These reports also explain investiga-
tions in which guinea pigs were injected with various doses of virulent tubercle 
bacilli inside their pleural cavity, developing granulomas in the liver, parasternal 
and para-aortic lymph nodes, spleen and kidneys, suggesting systemic dissemina-
tion. It all begins after the pleural space is invaded, disseminating to the thoracic 
lymph nodes and blood vessels, further seeding in distant organs.
6. Tuberculosis and organ system involvement
6.1 Central nervous system
Central nervous system tuberculous involvement occurs in approximately 
5–10% of extra pulmonary cases [14]. It is a rare disease within the whole tuber-
culosis spectrum. This presentation has the most dangerous and catastrophic 
consequences.
Developing of CNS tuberculous infection has been linked to decreased cellular 
immune response as seen in HIV patients, malnutrition, alcoholism, malignancies, 
and the use of immunosuppressive agents [14]. Children and adolescents are more 
commonly involved with meningitis as the clinical presentation compared to adults 
(>15-year-old patients). In a study published in 2011, the mean age of patients with 
meningeal involvement is reported to be lower than those patients with infection in 
other organs such as lymphatic, bone and/or joint, and genitourinary [6].
Cases of EPTB are more common in older patients; however, a study from 
2011 suggested that patients with ages less than 15 years old accounted for 5.4% 
of all TB patients. Although children were less likely to have EPTB, 13.8% of 
them presented as meningitis [6]. Peak of meningeal presentation was higher in 
patients younger than 24-year old. However, another study suggests that 40–70% 
of children with meningeal tuberculous involvement were exposed by older 
patients [15]. Risk factors related to meningitis by tuberculosis in children are 
similar to those related to infections in other sites, most cases related to some kind 
of immunosuppression. Median age of young patients with meningitis is approxi-
mately 4 y/o, and it is uncommon for children less than 6 months old to present 
with meningitis [15].
The most common clinical presentation of central nervous system involvement 
is meningitis. Most patients present with a history of nonspecific symptoms as mal-
aise, anorexia, fatigue, fever, myalgia, and headache for approximately 2–8 weeks 
prior to the development of meningeal irritation [14]. In addition, neck rigidity and 
typical meningitis symptoms are more common in adults. These symptoms include 
depressed consciousness and nonspecific behavioral changes [14]. Tuberculosis 
can also cause focal nervous system deficits. Intracranial tuberculoma is the least 
common presentation. They are mass-like lesions that can be found in 1% of extra 
pulmonary patients with cerebral involvement and present with symptoms and 
signs of focal neurological deficit without the evidence of systemic disease [17]. 
Involvement of the spine occurs in less than 1% of TB patients, and it can be sec-
ondary to subjacent bone or soft tissue involvement [14]. Approximately 10% of 
patients with CNS tuberculosis have evidence of pulmonary tuberculosis [16].
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Diagnosis of intracranial mycobacterium tuberculosis infection requires cerebral 
spinal fluid (CSF) cultures or acid fast stains obtained by spinal tap or tissue biopsy. 
Rates of CSF culture positivity for clinically diagnosed cases range from 25 to 70% 
[14]. In some cases, large volume spinal tap is required for diagnosis. However, HIV 
patients usually require less amount of fluid for diagnosis. Drug sensitivity testing is 
important for appropriate treatment. CSF sensitivity for culture and smear staining 
decrease significantly after treatment has been started [14], for which rapid diagno-
sis is essential to warrant the best outcome.
Polymerase chain reaction for Mycobacterium tuberculosis has also been used with 
variable results. Moreover, tuberculin skin tests and interferon gamma release assays 
could suggest exposure, but has limited utility for active disease diagnosis. Cerebral 
spinal fluid analysis for adenosine deaminase protein (ADA), an enzyme produced 
by lymphocytic proliferation differentiation during cell-mediated immunity, has 
also variable sensitivity for CNS infection. But standardized cutoffs have not been 
established. It has been used to predict CNS infection sequel that suggests poor out-
comes in patients with higher values [14]. However, ADA levels in CNS can be high 
in other infections and noninfectious CNS pathologies. Therefore, correct diagnosis 
still requires CSF or tissue sample for AFB stains and cultures for mycobacterium.
Prompt therapy initiation with intravenous medications is extremely important 
for the treatment of tuberculous meningitis. First, line therapy for tuberculous 
CNS infection includes a combination of isoniazid, rifampicin, pyrazinamide, and 
ethambutol, which has to be taken daily. The recommended minimum duration 
is 10 months of therapy, which can be extended to 12 months if any interruption 
occurs during therapy. All medications have good hematoencephalic penetrance. 
On the other hand, monotherapy is not recommended due to the risk of developing 
an antimycobacterial therapy resistance, especially with isoniazid.
CNS lesions causing mass effect and hydrocephalus may require neurosurgical 
evaluation and cerebral decompression.
Systemic anti-inflammatory therapy with steroids should be started con-
comitantly (see Table 1). The use of anti-inflammatory medication has shown to 
decrease mortality without additional risk of adverse events [18]. Based on animal 
studies, the benefit of steroid therapy results from the reduction of the inflam-
matory process with a subsequent decrease in cerebral and spinal cord edema and 
brain pressure [18], with less disruptions in blood flow and cerebral perfusion.
In view of this, early diagnosis and initiation of antituberculous therapy with 
systemic steroids are vital to decrease mortality and improve outcome in patient 
with CNS tuberculous infection.
6.2 Thoracic extra pulmonary tuberculosis
It is believed that the development of extra pulmonary manifestation starts after 
mycobacterium bacilli invade pleural cavity from subjacent pulmonary paren-
chyma and then migrates to the lymphatic system, blood vessels, and eventually 
to other organs outside the thoracic cavity. For this reason is important to rule out 
pulmonary parenchymal tuberculosis when a patient is suspected to have a pleural 
effusion secondary to pleural invasion. Manifestations of tuberculosis in the pleural 
cavity could present either as pleural effusion or empyema. Pneumothorax as a 
result to parenchymal cavitary lesion rupture can also be seen. All pleural tubercu-
lous involvements can end up in pleural tissue fibrosis or fibrothorax.
Fluid accumulates in the pleural cavity as a consequence of a hypersensitivity 
reaction to bacilli mycobacterium in the pleural space. Pleural tuberculosis occurs 
approximately in 5% of patient with tuberculosis in USA and can reach as high 
a 30% of patients within high prevalence populations [19]. Tuberculous pleural 
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effusions usually occur in the right side; these are small to moderate in size and are 
characterized as an exudate fluid. Fluid analysis is characterized with high protein 
levels (>5 g/dL), cell count around thousands, and lymphocytic predominance. It 
usually presents with more than 80% of lymphocytic predominance, and depend-
ing on the time of diagnosis, variable amounts of lymphocytes from 20 to 90% has 
been seen. In addition, low pH and low glucose levels can also be seen in pleural 
fluid analysis. Long standing effusions result in a highly acidic fluid. Lactate dehy-
drogenase enzyme (LDH) levels usually range above 500 IU/L [19].
Adenosine deaminase (ADA) levels (see CNS involvement) are of particular util-
ity in suspected tuberculous pleural effusions. The diagnostic use of ADA depends 
on its sensitivity and specificity and the regional prevalence of the infection. In a 
high prevalence population, an elevated ADA level (>40 U/L) is considered con-
firmatory with a clear indication for therapy. In low prevalence populations, a low 
ADA level (<40 U/L) has a high negative predictive value and therefore, rules out 
the diagnosis [19]. There are cases where ADA levels are not considered reliable, for 
example, in patients with pulmonary, pleural or hematologic malignancies, nontu-
berculous bacterial infections and also in those who underwent pleural procedures.
Acid fast staining and culture test have limited diagnostic utility. Patients with 
pleural effusions of unknown etiology should be evaluated for a possible infectious 
Infection site First line therapy Duration Adjunctive therapy
Central nervous 
system
1. Meningitis
2. Mass like lesion
1. Isoniazid, Rifampicin, 
Pyrazinamide*
Isoniazid, Rifampicin, 
Pyrazinamide*
1. 9–12 months
2. 9–12 months
1. Systemic steroids
2. Surgical Resection 
(if mass effect or 
hydrocephalus)
Thoracic extra 
pulmonary 
tuberculosis
1. Tuberculous 
Pleurisy
2. Empyema
Isoniazid, Rifampicin, 
Pyrazinamide and 
Ethambutol
6 months Percutaneous drainage or 
surgical evacuation
Gastrointestinal 
tuberculosis
Isoniazid, Rifampicin, 
Pyrazinamide and 
Ethambutol**
9–12 months
Genitourinary 
tuberculosis
Isoniazid, Rifampicin, 
Pyrazinamide and 
Ethambutol
6–12 months (2 
months of the 4 
drugs followed 
by 4 months of 
Isoniazid and 
Rifampin)
Surgical resection in case of 
genito-urinary obstruction
Skeletal tuberculosis Isoniazid, Rifampicin, 
Pyrazinamide and 
Ethambutol*
6–12 months (2 
months of the 4 
drugs followed 
by 4 months of 
Isoniazid and 
Rifampin)
Surgical resection in case of 
abscess formation or cord 
compression
Cutaneous 
tuberculosis
Isoniazid, Rifampicin, 
Pyrazinamide and 
Ethambutol
6–12 months Colchicine, NSAID’s, 
potassium iodine, 
dapsone, tetracyclines and 
antimalarial
*Streptomycin can be added based in susceptibility.
**Therapy also can be based on susceptibility including Levofloxacin, Linezolid and Streptomycin.
Table 1. 
Extra pulmonary tuberculosis treatment.
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cause, including tuberculosis. This is essential in patients with history of TB expo-
sure, immunosuppression (including HIV), and pleural effusions with nonspecific 
characteristics, and lymphocytic cell count predominance.
Acid-fast smears are almost always negative. Positive cultures for mycobacte-
rium tuberculosis have been reported in 10–70% of the cases [19], and consequently 
pleural fluid culture analysis has a low diagnostic yield. Positive culture is directly 
proportional to the level of immunosuppression. In an HIV patient, the yield 
doubles (20%) compared to the immunocompetent patient (10%). It is more com-
mon to obtain a positive culture in a liquid media versus solid media [19]. Positive 
pleural fluid cultures are useful for drug therapy sensitivity and should be obtained 
in every case of suspected tuberculous pleural effusion.
Pleural biopsy is considered one of the best diagnostic methods when tubercu-
lous pleurisy is suspected. Definite diagnosis is obtained if mycobacterial bacillus 
is detected in the smear, culture or pleural tissue biopsy. In the appropriate clinical 
setting, the presence of granuloma obtained after pleural biopsy is highly suggestive 
of tuberculous pleurisy and demands treatment.
Percutaneous biopsy has a yield of almost 90% when guided by ultrasound 
[18]. When pleural biopsy is performed, the instruments and technique used 
varies, but the yield improves when at least six samples are taken from different 
quadrants [20]. More invasive procedures such as thoracoscopy and open surgical 
biopsies have good diagnostic yields. Access to these techniques is limited in areas of 
endemic tuberculosis, and for this reason, less invasive work up is the usual diag-
nostic approach. When a pleural effusion is suspected to be of tuberculosis origin, 
without evidence of pulmonary parenchymal involvement, a positive ADA in 
endemic areas is considered diagnostic. A low ADA level (<40) needs further work 
up including pleural biopsy. In low prevalence populations, a low ADA almost rules 
out tuberculosis and in these cases other etiologies must be considered [18].
Treatment for isolated pleural tuberculosis does not differ from pulmonary 
tuberculosis. Unless the effusion is characterized as an empyema, drainage is not 
required, and the effusion is expected to resolve by itself in weeks after commence-
ment of treatment.
6.3 Gastrointestinal tuberculosis (abdominal tuberculosis)
Gastrointestinal tuberculosis (GI Tb) is relatively rare in the United States and 
is the sixth most common extrapulmonary location. Populations at risk include 
immigrants to the United States, the homeless, prisoners, residents of long-term care 
facilities, and the immunocompromised. The peritoneum and the ileocecal region are 
the most likely sites of infection and are involved in the majority of cases by hema-
togenous spread or through swallowing of infected sputum from primary pulmonary 
tuberculosis. Pulmonary tuberculosis is apparent in less than half of patients.
GI TB is a major health problem in many underdeveloped countries. In those 
with HIV infection, it is more present.
In those with pulmonary Tb, intestinal involvement was largely present before 
effective therapy was available.
However, approximately 20–25% of patients with GI TB have pulmonary 
TB. The ileum and colon are the common sites involved [21].
Other comorbidities associated with lower GI tract TB have been in other series 
type II diabetes mellitus (23%) and alcoholism (23%). Half of the stool cultures for 
Mycobacterium tuberculosis yields positive for it. This is similar to what is found with 
biopsy cultures of affected GI tract [22].
Treatment with 6 months antituberculous therapy has been found to be as effec-
tive as 9 months of therapy in patients with intestinal TB [23].
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6.4 Specific situations
Esophageal Tb is the least common site of Tb in the GI tract [24]. Stomach and 
duodenal involvement by TB is rare because of (1) the high acidity of peptic secre-
tions and (2) diminished amount of lymphoid tissue in the first part of the GI tract. 
Dyspepsia, diffuse abdominal pain, is frequent.
Clinical features of intestinal TB include abdominal pain, weight loss, anemia, 
and fever with night sweats. Patients may present with symptoms of obstruction, 
right sided pain [25].
Malabsorption may be caused by obstruction that leads to bacterial overgrowth, 
a variant of stagnant loop syndrome. Involvement of the mesenteric lymphatic 
system, known as tabes mesenterica, may retard chylomicron removal because of 
lymphatic obstruction and result in malabsorption.
The ileum is more commonly involved than the jejunum. Ileocecal involvement 
is seen in 80–90% of patients with GI TB. The latter is due to the abundance of 
lymphoid tissue in the distal ileum [26, 27].
If ascites is present, the measurement of ascitic fluid adenosine deaminase levels 
is reasonable. Laparoscopic biopsy samples from the peritoneum should be stained 
for acid-fast bacilli (AFB), and cultures should also be obtained with a reasonable 
yield [28, 29].
6.5 Genitourinary tuberculosis
Tuberculosis usually goes into the genitourinary system after reactivation of 
previous acquired disease. This is the second most common presentation of extra 
pulmonary disease, following lymphatic spread of infection [30]. Tuberculous 
bacilli infect renal and reproductive organs after they travel through the circulatory 
system. Genital involvement also occurs by cutaneous lesions during sexual contact 
or by contaminated instrumentation.
Genitourinary involvement mostly occurs after reactivation of latent disease, 
and time to reactivation occurs years after primary infection. Cases reported usu-
ally involve older patients with a median age above 40 year old and mostly affects 
male patients [23]. The urinary tract is usually involved and it can manifest as a 
simple cystitis or pyelonephritis with or without hematuria and renal failure.
When renal function is affected, the patient has urinary tract obstruction or 
an interstitial nephritis. The prostate, seminal vesicles, and epididymis are rarely 
affected. Epididymis is the most common genital organ involved in men followed 
by prostate [30]. Testicles involvement is very rare. In women, fallopian tubes and 
uterus are the most common genital organs involved and can cause infertility in 
small percent of young women [30].
Diagnosis is done showing evidence of bacilli in stain or cultures in urine or tis-
sue obtained from the genitourinary tract. Granulomas and acid-fast bacilli can also 
be seen in tissue specimens from kidneys and reproductive organs [31]. Treatment 
is usually the same as pulmonary tuberculosis, with approximately 6–8 months as 
the recommended duration of therapy.
6.6 Skeletal tuberculosis
Skeletal tuberculosis presents with certain variability. It is responsible about 
10% of all cases of extrapulmonary tuberculosis in the United States of America, 
with a highest prevalence among those immigrants who come from endemic areas. 
The proportion is no different between those patients infected with HIV versus 
those not infected. The most common affected area is the spine, follow tuberculous 
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arthritis, and follow by extraspinal osteomyelitis. Young individuals are more likely 
to be affected in highly endemic are while adult patients are more frequently in low 
endemic together with a late presentation [32, 33].
The associated pathogenesis resides in disease confinement at the bone and 
the synovial fluid. It results after seeding during primary infection. Cellular and 
adaptive response are responsible of disease containment until reactivation which 
related to immunity failing which can be seen in different settings including 
older age, renal failure, malnutrition, and acquired immune deficiencies. Skeletal 
involvement shows histopathological pattern of caseous exudative or granular. The 
first occurs more frequently in children and it is characterized by inflammatory 
changes, bone destruction, abscess, and sinus tract formation. The last is much 
slower and much less destructive. Any bone can be infected with tuberculosis. 
Clinical manifestations include spondylitis, arthritis, and osteomyelitis [33, 34].
Tuberculous spondylitis (also known as Pott’s disease) is the most common 
presentation. It is responsible for one half of the bone-related cases and most com-
monly affects the lower thorax and upper lumbar region. The infection starts at the 
anterior area of the vertebral joint and locally spreads to the anterior ligament after 
that it will affect the local vertebral body. Once the adjacent vertebra is affected, 
it proceeds to involve the intervertebral disk space with vertebral narrowing and 
further collapse. This finding may lead to distortion of the spinal canal anatomy and 
possible neurologic compromise. Although continuous spinal infection is uncom-
mon, it has been documented [35]. Less than 40% of the patients presents with fever 
and weight loss. Symptoms include progressive local pain over the weeks with asso-
ciated muscle spam and rigidity. The patient may present with an erect posture with 
associated short steps. Unfortunately, due to the lack of medical access on endemic 
regions, many of these patients will present with cord compression. Radiography 
changes are first appreciated in the anterior part of the vertebral body showing areas 
of demineralization and loss of margin contour. Findings of next vertebral involve-
ment are common. Sclerotic changes persist but the rest of the vertebra remains 
without involvement [36]. Although the disk is commonly obliterated, collected 
data show that multiple sites and sparing of the disk are possible [37].
Arthritis may occur as part of direct infectious process to the joint or due to an 
inflammatory response. The infectious process is monoarticular and may affect 
any joint but most commonly the hip. The symptoms progress from weeks to 
months and presents with chronic swelling, pain, and loss of function without 
erythema. Constitutional symptoms occur in less than 30% of the cases [38]. The 
joint presents with effusion and loss of function with associated granulomatous 
changes, such changes lead to distortion and deformity of the joint. Treatment may 
include total hip replacement if debridement and antituberculous treatment is given 
[39]. Prosthetic joints can also be affected but it is very rarely. While arthroplasty 
may have an adequate outcome, infections related to hardware may co-exist with 
other bacterial infections. The same is painful, and hardware needs to be removed. 
On the other hand, symmetrical polyarthritis may involve large and small joints 
without local evidence of active TB, despite the presence of military, pulmonary, or 
extrapulmonary manifestations of the disease. Poncet’s disease, other name given 
to the condition, seems to be immune-mediated and related to HIV co-infection. 
The inflammation resolves after starting antitubercular treatment without evidence 
of joint destruction [40]. Phemister triad may be observed in this case. The same 
consists of juxta-articular osteopenia or osteoporosis, peripheral osseous erosions, 
and gradual narrowing of the joint space. Although there is also evidence of local 
swelling and bode destruction, there is a preservation of the cartilage space.
Osteomyelitis may occur in any bone of the body, and it is more commonly 
insidious but the case has described acute and subacute onsets, which are very rare. 
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Clinical scenarios may include suspected malignancies or metastasis, but those find-
ings are due to lytic tubercular lesions. It presents in unusual areas such as symphysis 
pubis, elbow, and sacroiliac joint [41]. Small bones may be affected without evidence 
of active pulmonary disease [38]. Ribs and sternum may also be affected. The firs 
may be confused as a breast or chest wall mass. The second may occur after coronary 
bypass surgery due to previous mediastinal involvement or as primary focus [42]. 
Radiological evident is usually present at the time of clinical presentation. There 
is osteolytic changes with minimal or none inflammatory changes, periarticular 
osteopenia, soft tissue swelling, and minimal or periosteal elevation [43].
Musculoskeletal involvement may also be seen at the epidural space, as an 
extraspinal mass or psoas abscess. The presentation may cause cord compression, 
rib erosion, and sinus tracts to the groin, respectively.
The diagnosis of musculoskeletal tuberculosis is challenging considering its 
indolent progression and clinical presentation. Caliceal suspicion is warrant and 
detail travel history and exposition in needed. In addition, although, a chest X-ray 
neither includes nor excludes the presence of extrapulmonary manifestation, and it 
may give a clue of current situation or evidence of previous infection. Other studies 
such as computer tomography, myelography, and MRI help to describe in detail joint 
and spinal cord involvement. Biopsy with microscopy and culture of the suspected 
or infected area is need for drug testing and identification of isolates. Synovial 
biopsy is needed in case of TB arthritis is considered. The fluid may be aspirate and 
verified but findings and usually nonspecific. In case of findings or with draining 
sinus, culture of the latter may help to identify the pathogen, although polymicro-
bial isolates and fungal results may be present and misleading [44].
Treatment is very similar to pulmonary TB. However, the course of therapy 
relies in whether the drug regime includes rifampin or not. Data suggest that dose 
that include rifampin may be shorter and as equally as effective as longer treatments 
(6–9 vs. 9–12 months). Shorter courses such as 6 months may be suitable on those 
cases that involve radical surgical resections [45]. Also, randomized clinical trials 
show comparable results after 5 years of treatment on those patients who received 
isoniazid with rifampin for 6–9 months vs. those who received isoniazid with either 
paraminosalicylic acid or ethambutol. Sixteen surgeries are required in different 
settings such as chest wall abscess, spinal diseases with a kyphosis of more than 
40°, and spinal disease with progressive neurological deficits while on treatment 
or just advance neurological deterioration. This would lead to different alternatives 
such as decompression, drainage, debridement, and hardware placement for spine 
stabilization [46].
6.7 Cutaneous manifestations of tuberculosis
Although uncommon, tuberculosis also has skin manifestations. The same 
have been documented since 1826 and occurs in 1–2% of the infected individuals. 
Cutaneous classification varies, and it depends not only on clinical appearance but 
also on the method of infection, predisposing factors, and pre-existing TB expo-
sure. The bacterial load may be variable, the same may be easily or difficult to detect 
[47]. Mode of infection may be due to inoculation secondary to exogenous source, 
endogenous (continue infection), or hematogenous spread.
Exogenous inoculation can occur due to primary inoculation or due to tuber-
culosis verrucosa cutis (TBVC). Primary inoculation is rare and occurs after direct 
skin invasion of a previous nonsensitized patient. Children of endemic areas are 
more affected. However, surgical procedure with infected equipment, piercing, 
and tattoos has been identified as causals. The infection is clinically apparent by the 
fourth week. A painless brown papule or nodule shallow about 1 cm affecting the 
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face and extremities. The lesion progresses slowly, and regional painless lymphade-
nopathy develops. The same may cause sinus draining tracks following skin perfora-
tion. Diagnosis relies on the tissue sample, acid fast, and culture. If left untreated, 
the patient became sensitize to tuberculin test. Hematogenous spread is possible 
resulting military pattern [48].
On the other hand, TBVC occurs after direct inoculation in a patient who is already 
sensitized with TB. Children of endemic areas are at high risk and those who are occu-
pationally related. In children, the buttocks and ankles are more commonly affected, 
while in adults, it occurs more frequently at the fingers and the dorsum of the hands. 
It also presents with red-brown painless but warty plaques that grows peripherally. 
Ulceration and regional lymphadenopathy is not common, it may co-exist with bacte-
rial infection. Diagnose may be challenge. Culture form the lesion are usually negative, 
tuberculin test is positive, and interferon gamma assay may play a role in the diagnosis. 
Biopsy superficial dermal pseudoepitheliomatous hyperplasia with hyperkeratosis and 
microabscess in the dermis or pseudoepitheliomatous rete pegs. The upper and middle 
dermis shows inflammatory infiltrates of giant and epithelioid cells. Patient usually 
responds to anti-TB treatment. If left untreated, lesions may persist [49].
Cutaneous involvement may also be causes by contiguous spread presenting as 
Scrofuloderma, tuberculosis cutis orificialis, and lupus vulgaris. Scrofuloderma 
are painless red-brown nodules subcutaneously located most commonly at the 
axillar, neck, and groin areas. The infection occurs because of direct extension of 
the infection from deeps structures invading the skin. Cervical nodes are the most 
common site of infection. They tend to enlarge forming ulcers and sinus tracts and 
may follow a line lymphoid distribution. Although the infection has been related to 
Mycobacterium tuberculosis, it has been described in other in mycobacterial infec-
tions other than tuberculosis such as bovis and following BCG vaccination [49]. 
The lesion may be healed spontaneously, but it may take a long time to leave a scar. 
Lupus vulgaris may be developed in association to the later. Children, adolescents, 
and older adults are more commonly affected. Diagnosis is made by smear, culture, 
and biopsy. Tuberculin test is usually positive, and concomitant pulmonary disease 
is common [50].
Tuberculosis cutis orificialis (TBCO) is a rare manifestation of characterized by 
painful ulcers with pseudomembranous fibrous base from a prior red-yellow nodule 
with associated inflammation. The lesion may be sited at the oral, nasal, or anogenital 
area. It affects middle age and older adults with advance immunodeficient disease (cell-
mediated). Most of these patients already have a progressive, pulmonary, gastrointes-
tinal, or genitourinary advance TB disease. Tuberculin test is usually positive. Clinical 
course is usually poor leading to disseminated military TB. Diagnosis relies on biopsy 
smear and bacilli identification with the identification of them at the ulcer. The same is 
also associated with tubercular granulomas at the edge of the ulcer and deep dermis.
Lupus vulgaris results as a manifestation of TB reactivation. Is a chronic mani-
festation that can occur by direct extension, lymphatics, or hematogenous spread? 
It occurs more frequently on females than males, and it is the most common for old 
TB skin manifestation in Europe. Despite this, it has a different distribution which 
varies with geographical location. For example, in western countries, the distribution 
is more common located at the head and neck areas, while in subtropical or tropical 
areas is more common at the lower extremities [49]. The skin lesion is red-brown 
papule that progresses into a nonpainful plaque. The same grows up to 10 cm devel-
oping areas of atrophy with associated central clearing. There are also variations of 
the lesion, where it can develop hypertrophy and ulcerations. It may also infect with 
other infections. As can be appreciated in other forms of granulomatous disease, 
lesion can have a yellow-brown contour with “apple jelly” appearance [49]. Diagnosis 
may be difficult, since it cannot be detected by culture or histopathology. PCR plays 
Role of Microbes in Human Health and Diseases
12
a role in the identification of the mycobacteria. Although some cases have described, 
Mycobacterium bovis has potential pathogen. Pathology will show tuberculoid 
granulomas with central caseated lesions at the dermal area. The epidermal area may 
reveal atrophy acanthosis, hyperkeratosis. The disease, also known as Lupus TB, 
requires the use of anti Tb treatment. If not, the size of the lesion progresses develop-
ing ulceration of the skin with loss of architecture. Also, progression to skin-related 
cancer, such as squamous cell carcinoma, has been documented [50].
Skin lesion may also result from hematogenous spread from primary site of 
infection leading to metastatic tuberculous abscess, acute military TB, or lupus 
vulgaris. The first, metastatic tuberculous abscess occurs after developing cell-
mediated immunodeficiency occurring in adults and malnourished children. The 
abscess may be single or multiple forms subcutaneous nontender nodules that 
progress to ulcer and sinus tract formation without lymphadenopathy [49, 51]. Any 
part of the skin may be affected more commonly the extremities. The metastatic 
infection usually confers a poor prognosis in the predispose individuals. Diagnosis 
is done after the findings of bacillus formation in culture, smears, or biopsies. 
Histopathological, there is evidence of ample skin necrosis, may show granulomas 
at the dermis. Unfortunately, tuberculin test results are variable [51].
Acute miliary TB is a rare manifestation that occurs more frequently in patients 
with deficient cell-mediated immunity such as infants and acquired immunodefi-
ciency syndrome. Lesions are pinpoint red-bluish or purpuric papules with associ-
ated vesicles that furtherly become crusted. The lesion may resolve in the following 
weeks leaving hypopigmented scar like tissue. Skin biopsy plays a role in the diagno-
sis where mycobacteria are frequently identified. TST is usually negative [51].
Patient who have a higher immunity may develop hypersensitivity reaction 
manifestation as tuberculid. The lesions may be papulonecrotic, lichen scrofuloso-
rum, and erythema induratum of Bazin (EIB). The identification of a tuberculid 
is supported after the following: presence of detectable infection such a TST and 
interferon gamma release assay, identification of granulomatous lesion in the skin, 
failure to identify Mycobacterium tuberculosis in cultures and stains, and noted, the 
resolution of the skin lesions after anti-Tb treatment.
Papulonecrotic tuberculid is the most common. It occurs more frequently in 
children and young adults. It is a dark violaceous papule that progress to pus-
tular and necrosis. It is more commonly located in the face, neck, extremities 
extensor areas, and buttocks. It may be recurrent if left without treatment [51]. 
Constitutional symptoms occur prior the lesions and lymphadenitis can be appreci-
ated [51]. The lesions may resolve alone leaving residual scars. Diagnosis is based 
on history of TB and evidence of wedge necrosis at the dermal and epidermal areas 
with granulomatous inflammation, mycobacterial DNA identification, and prob-
able focus. TST is usually positive, and lesion resolves with anti-TB treatment.
Lichen scrofulosorum is rare and presents more frequently in children and 
young adult with previous infection at the lung, bone, lymph nodes, or intracranial. 
The lesion is small 1–5 mm red-brown -yellow commonly located at the truncal area 
[49, 51]. The lesions may resolve spontaneously without treatment. It does not leave 
a scar, and anti-TB treatment brings complete resolution. As other tuberculid, the 
diagnosis is based on clinical presentation, histopathologic findings (tuberculid 
granulomas at the upper dermis and tuber, glands, and hair follicles). TST is usually 
positive with negative mycobacterial culture.
Panniculitis of the lower extremity (EIB) may be seen in patients with TB. The 
manifestation usually occurs in middle age young females. The lesion is tender, 
red, subcutaneously located at the posterior aspects of the leg. The nodules may 
progress forming draining ulcers. Its course is chronic and resolves alone leaving 
scars. Anti-TB treatment is recommended. If panniculitis is associated to TB, TST is 
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often positive. Diagnosis is based on clinical history and histopathological find-
ings. Mycobacterial DNA may be identified by PCR but not always. Biopsy needs to 
include subcutaneous fat in a wedge fashion. The sample should reveal lobular with 
or without septal panniculitis, poorly form granulomas, necrosis of the fat with 
mixed inflammatory cells. Vasculitis may also. Other treatment alternatives include 
colchicine, NSAID’s, potassium iodide, dapsone, tetracyclines, and antimalarial. 
Other kind of tuberculid, similar to EIB, is the nodular pattern occurs at the same 
areas but the granulomatous findings occur at the dermal-subcutaneous fat junction 
without ulceration or evidence of panniculitis.
7. Conclusions
Tuberculosis can invade almost any organ through the lymphatic system and 
blood dissemination. The manifestations of extra pulmonary tuberculosis can be 
variable depending on the organ and the system involved. The diagnosis is made 
through a high suspicion in the predisposed populations, and many times, extensive 
diagnostic tests that usually involve cultures and/or biopsies of the infected tissue. 
This is one of the infectious affections with a greater range of presentations, capable 
of pretending to be other noninfectious diagnoses.
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